EHC

Business Context and Reporting Period

Company: HealthSouth Corporation (Note: Input metadata referenced "Encompass Health Corp," but the filing text identifies the registrant as HealthSouth Corporation).

Filing Type: Form 10-Q (Quarterly Report)

Reporting Period: Three and nine months ended September 30, 2001.

Business Overview: HealthSouth provides outpatient and rehabilitative healthcare services through inpatient and outpatient rehabilitation facilities, surgery centers, diagnostic centers, and medical centers. As of September 30, 2001, the company operated approximately 1,915 locations across 50 states and several international markets.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Revenues increased 1.5% ($15.4 million) for the quarter and 4.7% ($147.2 million) for the nine months compared to 2000. Same-store revenue growth was 5.3% for the quarter and 6.5% for the nine months, driven primarily by increased patient volume.
• Profitability Decline (YTD): While quarterly net income rose 11.4% to $79.1 million, nine-month net income fell 33.3% to $134.5 million (from $201.6 million in 2000). This decline is largely attributable to a one-time loss on sale of assets of $139.9 million recorded in 2001 related to the divestiture of occupational medicine operations and a medical center.
• Expense Management: Operating expenses as a percentage of revenue improved slightly to 66.4% for the quarter (from 67.1% in 2000) and 66.6% for the nine months (from 67.6% in 2000).
• Interest Costs: Interest expense decreased 15.5% for the quarter to $50.9 million due to lower effective interest rates, despite significant new debt issuances.

Guidance, Outlook, and Risks

• Capital Allocation: The company issued $600 million in new senior notes in September 2001 ($400 million 8-3/8% Notes due 2011 and $200 million 7-3/8% Notes due 2006) to pay down variable-rate credit facility debt. Proceeds from asset sales ($97.8 million) were also used to reduce indebtedness.
• Future Spending: Management anticipates spending $100–$150 million on maintenance/expansion and $200–$250 million on development activities over the next twelve months.
• Regulatory Risks: Significant exposure to changes in Medicare and Medicaid reimbursement policies. The company notes increasing pressure from payors to control costs and potential proposals to limit Medicare reimbursement.
• Legal Proceedings: The company is defending against consolidated securities class action lawsuits alleging misrepresentations regarding financial condition and the impact of the Balanced Budget Act of 1997. A hearing on class certification is scheduled for November 29, 2001. Management believes the claims are without merit but cannot predict the outcome.
• Accounting Changes: The company will adopt FASB Statement No. 142 (Goodwill and Other Intangibles) on January 1, 2002, which will require periodic impairment testing of goodwill rather than amortization.

Investor Verification Checklist

• Asset Sale Impact: Verify the specific details and future implications of the $139.9 million loss on the sale of occupational medicine and the Richmond medical center.
• Debt Structure: Confirm the shift from variable-rate debt to fixed-rate debt following the September 2001 bond issuances and the remaining balance on the $1.75 billion revolving credit facility ($613 million drawn).
• Reimbursement Rates: Monitor updates on Medicare/Medicaid reimbursement rates and the impact of the Balanced Budget Act on future margins.
• Legal Exposure: Track the status of the securities class action litigation and any potential settlement or judgment risks.
• Goodwill Impairment: Assess the potential financial impact of the upcoming adoption of FASB 142 on goodwill amortization and impairment testing.